What if a single tweak to your genetic code could banish gout and fatty liver forever—by bringing back a gene your ancestors lost millions of years ago?
Story Snapshot
- Scientists used CRISPR to reactivate a dormant gene in human liver models
- This gene, lost through evolution, controls uric acid and fat buildup
- The technique prevented both gout and fatty liver disease in lab tests
- The breakthrough points to a future of genetically engineered disease resistance
Restoring Ancient Genes Changes the Game
Researchers have taken a bold step beyond treating symptoms and have begun rewriting the rules of human biology. Using CRISPR gene-editing, teams have reactivated a gene in human liver cells that vanished from our lineage millions of years ago. This gene’s absence is the reason humans, unlike most mammals, suffer from high uric acid levels that can cause gout and why our livers are prone to accumulating damaging fat. By switching this gene back on, scientists reversed both problems in laboratory-grown human liver models.
CRISPR brings back ancient gene that prevents gout and fatty liver https://t.co/Gv8KXrZePY
— Zicutake USA Comment (@Zicutake) November 15, 2025
Gout, infamous for its sudden, searing joint pain, was once called the “disease of kings” due to its link with rich diets. Fatty liver disease, meanwhile, has become a modern epidemic tied to obesity and sugar intake. Both conditions stem from how our bodies process uric acid and fat—a process now shown to be manipulable at the genetic level. The return of this ancient gene slashed uric acid to safe levels and halted the kind of fat accumulation that triggers liver disease. The significance? This isn’t just symptom management, but a potential cure at the source.
Watch: CRISPR Revives Ancient Gene to Fight Gout & Fatty Liver: A Scientific Breakthrough
Why Did We Lose This Gene?
Humans and our great ape relatives lost the functionality of this gene—Uox, which encodes uricase, an enzyme that breaks down uric acid—during evolution. Most mammals use uricase to keep uric acid in check. For reasons still debated, our ancestors’ version of the gene mutated into silence. Some evolutionary biologists speculate this helped ancient hominids conserve antioxidants, which uric acid provides, in times of scarce food. The tradeoff? A lifetime of risk for gout and metabolic diseases in today’s calorie-rich world.
Reactivating Uox in human liver models not only lowered uric acid but also rebalanced fat metabolism. This dual effect hints that the evolutionary loss of uricase may have had more widespread metabolic consequences than previously realized. Restoring the gene didn’t just target one disease, but sabotaged two of modern medicine’s most stubborn foes.
The CRISPR Revolution: Editing Our Way to Healthier Futures
CRISPR, the revolutionary tool for editing DNA with striking precision, made this experiment possible. By inserting a functional copy of the uricase gene where the original had gone dormant, scientists achieved genetic changes that stuck, radically shifting cell metabolism. Unlike drugs that must be taken for life, or diets that demand relentless willpower, gene editing promises a permanent fix—at least in theory. Animal models and human cell cultures are the first steps, with human trials on the horizon.
The possibility of eradicating diseases like gout and fatty liver before they begin raises profound questions. If we can restore lost genes to prevent suffering, should we? What are the risks of reshaping our biology to fit modern lifestyles? As research moves from the lab to clinical trials, these questions will move from scientific journals to dinner tables and policy debates. The power to rewrite not just our future, but our evolutionary past, is now within reach.
Sources:
https://scitechdaily.com/scientists-revive-an-ancient-human-gene-that-could-help-cure-gout/
